Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Acute Hemostasis Following the Use of the AQUABEAM® System for the Treatment of Benign Prostatic Hyperplasia III

NCT04308070 is registered in ClinicalTrials.gov with PROCEPT BioRobotics as lead sponsor.

NCT NCT04308070
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04308070 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Acute Hemostasis Following the Use of the AQUABEAM® System for the Treatment of Benign Prostatic Hyperplasia III
Lead sponsor
PROCEPT BioRobotics
Phase
Not applicable
Overall status
Completed
Start date
July 18, 2017
Completion date
June 30, 2018
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

benign prostatic hyperplasia